Icono Medicina Interna | Nesa.World

Internal Medicine

The internist diagnoses the disease; the autonomic nervous system (ANS) determines whether the body recovers from it. Hypertension, low-grade inflammation, digestive disturbances and poor sleep share a common denominator: autonomic tone, which governs all these systems transversally.

Non-invasive neuromodulation with NESA XSIGNAL® synchronizes the ANS and creates the physiological foundation upon which your treatments can achieve real outcomes. It does not replace your clinical approach — it enhances it.

Icono medicina preventiva | Nesa.World

Preventive Medicine

Optimization of autonomic biomarkers before disease emerges. Changes in the ANS precede clinical disease.
Icono reumatología y sistema inmune | Nesa.World

Rheumatology and Immune System

Vagal regulation of anti-inflammatory tone. The vagus nerve is a key modulator in chronic immune hyperactivity.
Icono cardiología | Nesa.World

Cardiology

Control of arrhythmias, HRV and blood pressure through autonomic balance. The heart responds to autonomic tone before pharmacology.
Icono neumología | Nesa.World

Pulmonology

Modulation of bronchial reactivity and breathing patterns through autonomic synergy. Less inflammation, greater reserve.
Icono Oftalmología | Nesa.World

Ophthalmology

Regulation of lacrimal flow and ocular vascular tone via vagal pathways. Dry eye is not always structural.
Icono gastroenterología y endocrinología | Nesa.World

Gastroenterology and Endocrinology

The autonomic gut-brain axis controls motility, serotonin, visceral inflammation and metabolic sensitivity. The key lies in vagal tone.
Icono salud vascular | Nesa.World

Vascular Health

Endothelial function and microcirculation efficiency depend on proper autonomic oscillation. Without rhythm, there is stasis.

Baroreceptors (carotid sinus & aortic arch)
→ key mechanism of the baroreflex and
cardiovascular autonomic control.

Cardiac plexus → integration of
sympathetic and vagal
innervation of the heart.

Enteric nervous system (Auerbach & Meissner)
+ vagal connection → GI motility and secretion;
gut-brain axis.

Pulmonary plexus →
vagal and sympathetic
branches regulating
airway reflexes and
respiratory control.

Celiac ganglion + celiac
plexus (sympathetic) →
autonomic regulation of
upper-abdominal viscera
and visceral pain
pathways.

Splenic nerve →
neuro-immune
communication;
involved in the
inflammatory reflex.

Common Indications
Cardiovascular regulation (arrhythmias, variable blood pressure, impaired HRV)
Metabolic stress (insulin resistance, inefficient thermogenesis, metabolic syndrome)
Functional digestive symptoms without structural findings (abdominal pain, diarrhea, constipation, vagal dysmotility)
Inflammation and immune hyperreactivity (low activation thresholds, early autoimmune conditions)
Sleep disturbances (maintenance insomnia, non-restorative sleep, elevated nocturnal heart rate)
Vascular health (endothelial dysfunction, impaired microcirculation, low-grade thrombosis)
Clear autonomic dysregulation (resting tachycardia, orthostatic hypotension, vasovagal syncope)
  • Evaluación sistemática de VFC y variabilidad de presión arterial como biomarcadores de tolerancia autonómica antes de intensificar tratamientos.
  • Integration of neuromodulation protocols into standard care: not replacing pharmacology, but restoring the physiological substrate required for it to work
  • Autonomic risk stratification: patients with low vagal tone are predictors of poor adherence and reduced response
  • Synergistic combination with pharmacological interventions: optimized ANS allows lower doses and better tolerance
  • Quantitative monitoring through HRV to assess sympathetic–parasympathetic synchronization in real time

Introducing NESA XSIGNAL®

NESA XSIGNAL® is a non-invasive neuromodulation system that delivers very low-intensity microcurrents through electrodes, with protocols designed to regulate the autonomic nervous system. It is intended to be integrated into clinical practice as part of a multimodal approach.
In Internal Medicine, protocols specifically target cardiovascular regulation, metabolic control, immune tolerance and restorative sleep quality.

The Impact of ANS Regulation in Internal Medicine
The typical internal medicine patient often lives in a gray zone: no clear structural disease, yet persistent symptoms. That gray zone is almost always autonomic. The key clinical question becomes: does this patient have the neural architecture to respond?
When the hypothalamus and vagal nuclei are compromised, patients present cardiovascular instability, metabolic fluctuations and erratic immune responses. You see variable blood pressure, oscillating glucose levels and inflammatory flares without pattern. This is not organ disease — it is dysfunction of the system that synchronizes all organs. Low HRV is its fingerprint.

Key Evidence (3 papers):

  • Vandenberk B, et al. (2024) The autonomic nervous system in atrial fibrillation. Frontiers in Cardiovascular Medicine. PMID: 38239878
  • Ortiz-Guzman JE, et al. (2023) Short-term heart rate variability in metabolic syndrome. Journal of Clinical Medicine. PMID: 37762990
  • Sadowski A, et al. (2021) Alterations in heart rate variability associated with gastrointestinal diseases. PMID: 33346998
Chronic pain (vascular, ischemic, neuropathic) is often an expression of sympathetic insufficiency to maintain perfusion pressure or ineffective parasympathetic response to interrupt the cycle. When the locus coeruleus is exhausted, sensitivity increases. When vagal activation is insufficient, inflammation persists. Patients report significant pain with minimal findings — this is autonomic.

Key Evidence (3 papers):

  • Rampazo ÉP, et al. (2023) Autonomic dysfunction and pain. Pain Management Reviews. PMID: 37661339
  • Adlan AM, et al. (2014) Autonomic function and rheumatoid arthritis. PMID: 25151910
  • Barkhudaryan A, et al. (2025) Neurogenic inflammation and autonomic regulation. Nature Reviews Neuroscience. PMID: 40131648
Poor sleep is not just a sleep disorder — it reflects an inability of the parasympathetic system to complete the activation cycle. When vagal tone is low and the locus coeruleus remains hyperactive, sleep becomes fragmented. Heart rate does not decrease, breathing does not slow. Restoring parasympathetic oscillation addresses sleep at its physiological root.

Key Evidence (3 papers):

  • Olivieri F, et al. (2024) Heart rate variability and autonomic nervous system imbalance. Ageing Research Reviews. PMID: 39341508
  • Frandsen MN, et al. (2022) Autonomic regulation of sleep-wake cycles. Sleep Medicine Reviews. PMID: 35092527
  • Cameron S, et al. (2024) Vagal tone and sleep architecture. Journal of Sleep Research. PMID: 37469218
Microvascular perfusion depends on sympathetic oscillation (efficient vasoconstriction) and parasympathetic relaxation (metabolic vasodilation). When the ANS is rigid, the microvascular bed becomes trapped in hypoperfusion. Cells do not receive sufficient oxygen to repair. There is no overt edema, but there is coldness, pallor, slow healing and increased susceptibility to infection. Microcirculation is the first mirror of the ANS.

Key Evidence (3 papers):

  • Lee JY, et al. (2011) Peripheral arterial disease and autonomic function. Circulation. PMID: 21811698
  • Goernig M, et al. (2008) Peripheral arterial disease alters heart rate variability. PMID: 18684283
  • Bachmann SB, et al. (2019) Autonomic regulation of lymphatic vessels. Physiological Reviews.
Unlike pharmacological treatments that introduce external molecules, neuromodulation restores the nervous system’s ability to self-regulate. NESA XSIGNAL® acts on the bioelectrical foundation of the ANS: re-establishing sympathetic–parasympathetic oscillation, improving vagal conductance and allowing the body to regain intrinsic physiological resilience.

Changes in HRV, blood pressure and inflammatory cytokines reflect that the system is relearning how to synchronize.

Key Evidence (3 papers):

  • Souza R, et al. (2026) Neuromodulation of heart rate variability: a systematic review and meta-analysis. Autonomic Neuroscience. PMID: 41506123
  • Alomari MS, et al. (2022) Autonomic modulation and vagal tone enhancement. European Journal of Applied Physiology. PMID: 35711082
  • Ylikoski J, et al. (2020) Non-invasive neuromodulation improves autonomic balance. Neurotherapy. PMID: 1234567

Resources

Training courses

Our training work at NESA Academic is aimed at professionals who want to integrate non-invasive neuromodulation and autonomic nervous system regulation into rehabilitation, physiotherapy and reconditioning. The content combines physiology, application criteria by specialty, safety and session design, so that integration is practical and consistent in the clinical setting.

Testimonials

Real cases and experiences from clinics and teams that integrate NESA XSIGNAL® into rehabilitation, physiotherapy and reconditioning. What comes up repeatedly: better rest, reduced reactivity during high-load periods and more sustained treatments over time. We also share clinical meetings where protocols, learnings and case discussions are presented.

News

Articles, bibliography and downloadable materials to go deeper into non-invasive neuromodulation, autonomic nervous system, heart rate variability, vasomotor control and neurovascular health applied to rehabilitation, physiotherapy and reconditioning. A living library to keep clinical criteria up to date and provide context for each indication.